Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation

Objective: Tyloxapol is a non-ionic surfactant with diverse pharmacological effects including anti-inflammatory, anti-malignant tumor and antioxidant activities. However, the effect of tyloxapol on osteoclastogenesis has not been elucidated. In this study, we intended to clarify the effect of tyloxa...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Wen Guo, Haijun Li, Yan Lou, Yue Zhang, Jia Wang, Ming Qian, Haifeng Wei, Jianru Xiao, Youjia Xu
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2021-05-01
סדרה:	Journal of Orthopaedic Translation
נושאים:	Tyloxapol Osteoporosis Osteoclast Osteoblast Nuclear factor kappa-B (NF-κB) Mitogen-activated protein kinase (MAPK)
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2214031X21000061
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!